AbbVie (ABBV) has reportedly made three offers to acquire Shire (SHPG) in a bid to lock up Shire’s ADHD and rare drug franchise and capitalize on Shire’s tax-friendly Irish address.
AbbVie (ABBV) has reportedly made three offers to acquire Shire (SHPG) in a bid to lock up Shire’s ADHD and rare drug franchise and capitalize on Shire’s tax-friendly Irish address.